ribociclib,naporafenib,rineterkib,trametinib
novartis
['lba40', 'napora', 'melanoma']
#esmo22 something for immunotherapy resistant nras melanoma patients: naporafenib combinations, abstract lba40, 21% response rate and 61% dcr in pretreated mel patients 
Ph.D biologist and #Melanoma Patient Advocate